Richard Welbourn

Richard Welbourn

Auto-generated profile, based on publicly available information

Richard Welbourn

Department of Upper Gastrointestinal and Bariatric Surgery, Musgrove Park Hospital, Taunton, UK

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2018 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
RWRichard Welbourn
Richard Welbourn
MHMarianne Hollyman
Marianne Hollyman
RKRobin Kinsman
Robin Kinsman
JDJohn Dixon
John Dixon
RLRonald Liem
Ronald Liem
JHJacques Himpens
Jacques Himpens

6 June 2012 in Endocrinology
Verified
Journal Article
Open access
PDF file
DPDimitri J. Pournaras
Dimitri J. Pournaras
CGClare Glicksman
Clare Glicksman
RVRoyce Vincent
Royce Vincent
SKShophia Kuganolipava
Shophia Kuganolipava
JAJamie Alaghband-Zadeh
Jamie Alaghband-Zadeh
Carel W. Le RouxCarel W. Le Roux
Carel W. Le Roux
Gastric bypass leads to the remission of type 2 diabetes independently of weight loss. Our hypothesis is that changes in bile flow due to the altered anatomy may partly explain the metabolic outcomes of the operation. We prospectively studied 12 patients undergoing gastric bypass and six patients undergoing gastric banding over a 6-wk period. Plasma fibroblast growth factor (FGF)19, stimulated by bile acid absorption in the terminal ileum, and plasma bile acids were measured. In canine and rodent models, we investigated changes in the gut hormone response after altered bile flow. FGF19 and total plasma bile acids levels increased after gastric bypass compared with no change after gastric banding. In the canine model, both food and bile, on their own, stimulated satiety gut hormone responses. However, when combined, the response was doubled. In rats, drainage of endogenous bile into the terminal ileum was associated with an enhanced satiety gut hormone response, reduced food intake, and lower body weight. In conclusion, after gastric bypass, bile flow is altered, leading to increased plasma bile acids, FGF19, incretin. and satiety gut hormone concentrations. Elucidating the mechanism of action of gastric bypass surgery may lead to novel treatments for type 2 diabetes.

18 August 2017 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
RWRichard Welbourn
Richard Welbourn
DPDimitri J. Pournaras
Dimitri J. Pournaras
JDJohn Dixon
John Dixon
KHKelvin Higa
Kelvin Higa
RKRobin Kinsman
Robin Kinsman
NZNatan Zundel
Natan Zundel

16 July 2021 in British Journal of Surgery
Verified
Journal Article
Closed access
ARA G N Robertson
A G N Robertson
TWT Wiggins
T Wiggins
FRF P Robertson
F P Robertson
LHL Huppler
L Huppler
BDB Doleman
B Doleman
RWR Welbourn
R Welbourn
Background: Bariatric surgery is an established treatment for severe obesity; however, fewer than 1 per cent of eligible patients undergo surgery. The perceived risk of surgery may contribute to the low uptake. The aim of this study was to determine perioperative mortality associated with bariatric surgery, comparing different operation types and data sources. Methods: A literature search of Ovid MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials was conducted to identify studies published between 1 January 2014 and 31 July 2020. Inclusion criteria were studies of at least 1000 patients reporting short-term mortality after bariatric surgery. Data were collected on RCTs. Meta-analysis was performed to establish overall mortality rates across different study types. The primary outcome measure was perioperative mortality. Different operation types were compared, along with study type, in subgroup analyses. The study was registered at PROSPERO (2019: CRD 42019131632). Results: Some 4356 articles were identified and 58 met the inclusion criteria. Data were available on over 3.6 million patients. There were 4707 deaths. Pooled analysis showed an overall mortality rate of 0.08 (95 per cent c.i. 0.06 to 0.10; 95 per cent prediction interval 0 to 0.21) per cent. In subgroup analysis, there was no statistically significant difference between overall, 30-day, 90-day or in-hospital mortality (P = 0.29). There was no significant difference in reported mortality for RCTs, large studies, national databases or registries (P = 0.60). The pooled mortality rates by procedure type in ascending order were: 0.03 per cent for gastric band, 0.05 per cent for sleeve gastrectomy, 0.09 per cent for one-anastomosis gastric bypass, 0.09 per cent for Roux-en-Y gastric bypass, and 0.41 per cent for duodenal switch (P < 0.001 between operations). Conclusion: Bariatric surgery is safe, with low reported perioperative mortality rates.

11 May 2016 in BMJ
Verified
Journal Article
Closed access
PDF file
RWRichard Welbourn
Richard Welbourn
Carel W. Le RouxCarel W. Le Roux
Carel W. Le Roux
AOAmanda Owen-Smith
Amanda Owen-Smith
SWSarah Wordsworth
Sarah Wordsworth
JBJane M Blazeby
Jane M Blazeby
The number of people getting bariatric surgery is falling despite rising rates of obesity and diabetes. Richard Welbourn and colleagues examine why and argue that better access has potential to reduce long term costs of care

14 October 2009 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
DPDimitrios J. Pournaras
Dimitrios J. Pournaras
AOAlan Osborne
Alan Osborne
SHSimon C. Hawkins
Simon C. Hawkins
DMDavid Mahon
David Mahon
MGMohammad A. Ghatei
Mohammad A. Ghatei
Carel W. Le RouxCarel W. Le Roux
Carel W. Le Roux